US Aid Cuts Endanger Ghana’s Child Immunisation Gains

Funding Gap Looms as US Reduces Health Aid

The United States has announced a reduction in its health assistance to Ghana that creates an estimated $78.2 million shortfall for the 2024‑2025 fiscal year. The cut follows a broader review of foreign aid priorities and comes at a time when Ghana’s public‑health system is still recovering from the economic shocks of the past few years. USAID cited shifting strategic focus as the reason for the reduction, but the impact on the ground is already being felt.

Impact on Routine Immunisation Services

Routine immunisation in Ghana relies heavily on external financing to purchase vaccines, support cold‑chain logistics, and fund outreach campaigns in remote areas. The funding gap threatens several key components:

Procurement of pentavalent, measles‑rubella and oral polio vaccines.
Maintenance of refrigeration units in district health facilities.
Training of community health workers who deliver vaccines in hard‑to‑reach villages.
Monitoring and data‑collection systems that track coverage rates.

Without the expected US contribution, the Ministry of Health may have to delay or scale back planned vaccination drives, especially in the northern regions where coverage has historically lagged.

Ghana’s Recent Gains in Vaccine Coverage

Over the past decade Ghana has been praised for its steady improvement in child immunisation. According to the World Health Organization, the proportion of children receiving the full schedule of basic vaccines rose from 68 percent in 2010 to 86 percent in 2022. This progress helped reduce deaths from measles, diphtheria and pertussis by more than half.

Key factors behind the success include:

Strong political commitment from successive governments.
Partnerships with global initiatives such as GAVI, the Vaccine Alliance, which subsidises vaccine costs.
Community‑based outreach that brings vaccines to schools and market centres.
Robust data systems that allow rapid identification of gaps.

These achievements are fragile. The current funding shortfall could reverse years of progress, especially if catch‑up campaigns are postponed.

International Response and Funding Options

Global partners have already signalled concern. The UNICEF office in Accra warned that a funding gap of this magnitude could lead to a resurgence of vaccine‑preventable diseases within two years. Meanwhile, the World Bank is exploring a fast‑track financing facility to bridge the shortfall, but such mechanisms typically require co‑financing from the recipient government.

Potential avenues for Ghana include:

Negotiating a phased reinstatement of US funds based on measurable outcomes.
Seeking additional grants from the European Union’s health programmes.
Leveraging private‑sector philanthropy focused on child health.
Increasing domestic budget allocations for health, a step encouraged by the Ghana Ministry of Health.

Each option carries trade‑offs between speed, sustainability and political feasibility.

What the Shortfall Means for Children

For families on the front lines, the funding gap translates into fewer vaccination days and longer travel distances to health centres. In the Ashanti and Upper West regions, where community health volunteers already face logistical challenges, a reduction in outreach teams could leave thousands of infants unprotected.

Health experts warn that a dip in coverage below the 80 percent threshold could trigger outbreaks of measles and polio, diseases that Ghana has largely kept at bay. The economic cost of an outbreak—hospitalisation, lost productivity and emergency response—often exceeds the cost of preventive immunisation by a wide margin.

In addition to disease risk, the shortfall may affect data quality. Ghana’s health information system, praised for its real‑time dashboards, relies on funding for software licences and training. A slowdown could impair the ability to detect early warning signs of declining coverage.

Community leaders are already mobilising to fill the gap. In the town of Wa, local women’s groups have organised fundraising events to purchase solar‑powered refrigerators, ensuring that vaccines remain viable during power outages. Such grassroots efforts demonstrate resilience but cannot replace the scale of national funding.

Ultimately, the situation underscores the interconnected nature of global health financing. When a major donor reduces its contribution, the ripple effects are felt in clinics, schools and households across the country. Maintaining Ghana’s hard‑won immunisation gains will require coordinated action from both international partners and domestic stakeholders.